User's Manual
Table Of Contents
- Telemetry Transmitter
- Table of Contents
- Conventions Used in This Manual 1-1
- Nurses 1-7
- Monitor Technicians 1-7
- Biomedical Engineers 1-7
- Physicians 1-7
- Patients 1-7
- Sources of Interference 1-8
- Potential Sources of Damage 1-8
- Optional Leadwire Grouper 2-3
- Leadwire Color Codes 2-4
- Telemetry Channel Label 2-5
- Adult Electrode Placement 3-3
- Lead Fault Indication 3-4
- Noise Detection 3-4
- False Alarms 3-5
- Traditional Pulse Oximetry 3-5
- Electrodes, Leadwires, Sensors, and Sensor Cables 3-7
- Electrodes, Leadwires, Sensors and Sensor Cables 3-8
- Spacelabs Healthcare Technology 3-13
- Additional Information for Telemetry Products 3-13
- Telemetry 3-13
- Heart Rate Averaging 3-13
- Spacelabs Healthcare SpO2 Sensors 3-18
- Additional Information 3-18
- Transmitter Batteries 4-1
- Host Monitors 4-2
- Telemetry Receiver Module 4-2
- Assigning a Telemetry Channel 4-3
- Top, Front and Bottom View (96281-C) 4-4
- Rear View (96281-C) 4-5
- Front View (96281-A) 4-6
- Battery Compartment (96281-A, 96281-B, 96281-C) 4-7
- ECG 4-12
- SpO2 4-14
- Cleaning/Disinfecting 5-1
- Recommended Cleaning Solutions 5-2
- Basic Cleaning and Low-level Disinfection 5-3
- Cleaning ECG Leadwires 5-3
- Cleaning Buttons 5-3
- Cleaning the Battery Cover 5-3
- Table 1—Electromagnetic Emmissions A-1
- Table 2—Electromagnetic Immunity A-2
- Table 2—Electromagnetic Immunity (continued) A-3
- Table 3—Separation Distances A-4
- Introduction
- About the Transmitters
- ECG and SpO2
- ECG Overview
- Patient Preparation and Electrode Application
- To Set Up ECG Monitoring
- ECG Problem Solving
- SpO2 Overview
- Warnings and Cautions for SpO2
- Setting Up SpO2 Monitoring
- Ensuring Accurate SpO2 Monitoring
- SpO2 and Pulse Rate Specifications
- Using the Sensorwatch Feature
- Enabling and Adjusting Alarms
- Data Averaging
- Display Details at the Host Monitor
- Printing SpO2 Waveforms
- SpO2 Messages at the Host Monitor
- Sensors
- SpO2 Alarm Delays
- SpO2 Troubleshooting Guide
- Basic Operations
- Getting Started
- Basic Components
- Selecting Options for Leads
- Basic User Actions
- Basic Modes of Operation
- View Mode
- Status Messages at the Host Monitor
- Telemetry Transmitter with ECG Only Troubleshooting Guide
- Telemetry Transmitter with Display Troubleshooting Guide
- Telemetry Transmitter with Display and SpO2 Troubleshooting Guide
- Cleaning, Disinfecting, and Sterilization
- Appendix A — Guidance and Manufacturer’s Declaration
- Appendix B — Symbols
TELEMETRY TRANSMITTER (96281) OPERATIONS MANUAL 1-6
I NTRODUCTION
- The installer/user of a transmitter operating in the band of 608-614 MHz shall ensure that it
is at least 80 km from the Dominion Radio Astrophysical Observatory (DRAO) near
Pentiction, British Columbia. The coordinates of DRAO are: latitude N 49° 19’ 15”, longitude
W 119°37’ 12”. For medical telemetry systems not meeting this 80 km separation (e.g. the
Okanagan Valley, British Columbia) the installer/user must coordinate with, and obtain
written the concurrence of, the Director of DRAO before the equipment can be installed or
operated. The Director of DRAO may be contacted at 250-497-2300 (telephone) or 250-
497-2355 (fax). (Alternatively, the Manager, Regulatory Standards, Industry Canada, may
be contacted.)
- Transmitters operating in the bands 1395-1400 MHz or 1429-1432 MHz shall not be
operated in the areas of Sydney, Nova Scotia, or Gander, Newfoundland and Labrador.
Please contact the local Industry Canada Office for further information.
- Transmitters operating in the bands 608-614 MHz, 1395-1400 MHz or 1429-1432 MHz
comply with Industry Canada licence-exempt RSS standard(s). Operation is subject to the
following two conditions: (1) this device may not cause interference, and (2) this device
must accept any interference, including interference that may cause undesired operation of
the device.
• The user of this equipment is not authorized to make any changes or alterations that could
compromise the national certifications.
• Operation of hand-held, wireless telephone equipment (cordless telephones, cellular
telephones) near telemetry systems may cause interference and should be discouraged.
While personal communication devices are turned on, a separation of >6.5 feet (>2 meters)
should be maintained between personal communication devices and interior walls, the
patient cables, and any electronic medical device to which the patient may be connected.
Patients should not use any type of electronic communication equipment while connected to
any electronic medical device without an on-site evaluation by the biomedical staff. Two-
way radio equipment and other personal communication devices must be evaluated on site
to determine if additional space limitations are needed.
• Telemetry equipment is authorized to operate license exempt in the European Union’s (EU)
Harmonized 433 to 434 MHz Short Range Device (SRD) band. Telemetry equipment
operating in this band may not cause interference and must accept interference from other
devices found in the band. Many countries outside the EU also permit access to this band
for qualifying devices.
• Operation of telemetry equipment in the 608 to 614 MHz bands (part of the Wireless
Medical Telemetry Service (WMTS)) and in authorized spectrum of each country may be
geographically restricted by government regulation. Operation of this equipment in all U.S.
WMTS bands requires coordination and registration with the FCC-designated frequency
coordinator.
• Operation of telemetry equipment in the 1395 to 1400 MHz and 1429 to 1432 MHz bands
(part of the Wireless Medical Telemetry Service (WMTS)) and in authorized spectrum of
each country may be geographically restricted by government regulation. Operation of this
equipment in all U.S. WMTS bands requires coordination and registration with the
FCC-designated frequency coordinator.
• Operation of this equipment may be subject to liscensing requirements by your local
telecommunications authority. Check with your Spacelabs Healthcare field service
engineer.
• Users of medical telemetry equipment are cautioned that the operation of the equipment
could result in harmful interference to other nearby medical devices.
D R A F T
22 June 2012